P53‑microRNA interactions regulate the response of colorectal tumor cells to oxaliplatin under normoxic and hypoxic conditions.
- Published in:
- Oncology Reports, 2023, v. 50, n. 6, p. N.PAG, doi. 10.3892/or.2023.8656
- By:
- Publication type:
- Article
Works matching IS 1021335X AND DT 2023 AND VI 50 AND IP 6
Results: 16
1
2
Cucurbitacin E inhibits the proliferation of glioblastoma cells via FAK/AKT/GSK3β pathway.
- Published in:
- Oncology Reports, 2023, v. 50, n. 6, p. N.PAG, doi. 10.3892/or.2023.8658
- By:
- Publication type:
- Article
3
HELQ as a DNA helicase: Its novel role in normal cell function and tumorigenesis (Review).
- Published in:
- Oncology Reports, 2023, v. 50, n. 6, p. N.PAG, doi. 10.3892/or.2023.8657
- By:
- Publication type:
- Article
4
MicroRNA‑mediated regulation in lung adenocarcinoma: Signaling pathways and potential therapeutic implications (Review).
- Published in:
- Oncology Reports, 2023, v. 50, n. 6, p. N.PAG, doi. 10.3892/or.2023.8648
- By:
- Publication type:
- Article
5
Cancer therapeutic trispecific antibodies recruiting both T and natural killer cells to cancer cells.
- Published in:
- Oncology Reports, 2023, v. 50, n. 6, p. N.PAG, doi. 10.3892/or.2023.8649
- By:
- Publication type:
- Article
6
KLF4 suppresses the proliferation of perihilar cholangiocarcinoma by negatively regulating GDF15 and phosphorylating AKT.
- Published in:
- Oncology Reports, 2023, v. 50, n. 6, p. N.PAG, doi. 10.3892/or.2023.8659
- By:
- Publication type:
- Article
7
Cyclosporin A inhibits prostate cancer growth through suppression of E2F8 transcription factor in a MELK‑dependent manner.
- Published in:
- Oncology Reports, 2023, v. 50, n. 6, p. N.PAG, doi. 10.3892/or.2023.8655
- By:
- Publication type:
- Article
8
Analysis of the expression and mechanism of follistatin‑like protein 1 in cervical cancer.
- Published in:
- Oncology Reports, 2023, v. 50, n. 6, p. N.PAG, doi. 10.3892/or.2023.8652
- By:
- Publication type:
- Article
9
Licochalcone A induces cell cycle arrest and apoptosis via suppressing MAPK signaling pathway and the expression of FBXO5 in lung squamous cell cancer.
- Published in:
- Oncology Reports, 2023, v. 50, n. 6, p. N.PAG, doi. 10.3892/or.2023.8651
- By:
- Publication type:
- Article
10
Heterogeneity and individualized treatment of microenvironment in glioblastoma (Review).
- Published in:
- Oncology Reports, 2023, v. 50, n. 6, p. N.PAG, doi. 10.3892/or.2023.8654
- By:
- Publication type:
- Article
11
Starvation insult induces the translocation of high mobility group box 1 to cytosolic compartments in glioma.
- Published in:
- Oncology Reports, 2023, v. 50, n. 6, p. N.PAG, doi. 10.3892/or.2023.8653
- By:
- Publication type:
- Article
12
PRMT1 accelerates cell proliferation, migration, and tumor growth by upregulating ZEB1/H4R3me2as in thyroid carcinoma.
- Published in:
- Oncology Reports, 2023, v. 50, n. 6, p. N.PAG, doi. 10.3892/or.2023.8647
- By:
- Publication type:
- Article
13
[Corrigendum] Sulforaphane sensitizes human cholangiocarcinoma to cisplatin via the downregulation of anti‑apoptotic proteins.
- Published in:
- Oncology Reports, 2023, v. 50, n. 6, p. N.PAG, doi. 10.3892/or.2023.8646
- By:
- Publication type:
- Article
14
Emerging histological and serological biomarkers in oral squamous cell carcinoma: Applications in diagnosis, prognosis evaluation and personalized therapeutics (Review).
- Published in:
- Oncology Reports, 2023, v. 50, n. 6, p. N.PAG, doi. 10.3892/or.2023.8650
- By:
- Publication type:
- Article
15
Targeting of STAT5 using the small molecule topotecan hydrochloride suppresses acute myeloid leukemia progression.
- Published in:
- Oncology Reports, 2023, v. 50, n. 6, p. N.PAG, doi. 10.3892/or.2023.8645
- By:
- Publication type:
- Article
16
[Retracted] miR‑25 promotes metastasis via targeting FBXW7 in esophageal squamous cell carcinoma.
- Published in:
- Oncology Reports, 2023, v. 50, n. 6, p. N.PAG, doi. 10.3892/or.2023.8644
- By:
- Publication type:
- Article